D-0637-2024 Class II Ongoing

Recalled by Teva Pharmaceuticals USA, Inc — Parsippany, NJ

Recall Details

Product Type
Drugs
Report Date
August 28, 2024
Initiation Date
August 8, 2024
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7,080 unit dose packets

Product Description

Testosterone Gel, 1.62%, (Alcohol 80% v/v), 30 unit-dose packets, Rx Only, Teva Pharmaceuticals, USA, Inc. North Wales, PA 19454, NDC 0591-2925-30. Packet NDC # 0591-2925-32 Carton NDC # 0591-2925-30

Reason for Recall

Superpotent Drug

Distribution Pattern

Product was distributed nationwide within the United States

Code Information

Lot #: 100042386, Exp. Date 06/2025